AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Cervantes Corp Ltd

0.009

0.000

Volume:- -

Turnover:53.98K

Market Cap:17.19M

PE:-18.67

High:0.009

Open:0.009

Low:0.009

Close:0.009

52wk High:0.009

52wk Low:0.009

Shares:1.91B

Float Shares:836.00M

Volume Ratio:0.43

T/O Rate:- -

Dividend:- -

Dividend Rate:- -

EPS(TTM):0.000

EPS(LYR):0.000

ROE:-16.17%

ROA:-7.57%

PB:4.97

PE(LYR):-18.67

Loading ...

Overview Company News Filings

CVS Health Increasingly Likely to Reach 3% Medicare Advantage Target Margin in 2028, RBC Says

MT Newswires Live

Sector Update: Health Care

MT Newswires Live

GUIDANCE: (CVS) CVS Health Expects 2026 Adjusted EPS Range $7.30 - $7.50, vs. FactSet Est of $7.16

MT Newswires Live

A Look At CVS Health (CVS) Valuation After Guidance Reaffirmation And Medicare Advantage Update

Simply Wall St.

CVS Health's Aetna Says 88% of Prior Authorization Volume Standardized

MT Newswires Live

Did Insulin-Settlement Tailwinds and Medicare Advantage Boosts Just Shift CVS Health's (CVS) Investment Narrative?

Simply Wall St.

A Look At CVS Health’s Valuation As Medicare Advantage Rates Rise And FTC Insulin Concerns Ease

Simply Wall St.

Top Premarket Gainers

MT Newswires Live

Antitrust Lawsuit Targeting CVS, Colgate-Palmolive, Other Firms Dismissed by Federal Judge

MT Newswires Live

Should FTC Insulin Settlement And PBM Lawsuit Shift How Investors View CVS Health’s (CVS) Risk-Reward Profile?

Simply Wall St.

Sector Update: Health Care Stocks Advance Late Afternoon

MT Newswires Live

A Look At CVS Health (CVS) Valuation After Google Cloud Deal Board Change Lawsuit And Dividend News

Simply Wall St.

Is CVS Health (CVS) Pricing Look Interesting After Recent 1 Year Share Price Recovery

Simply Wall St.

Does Medicare Advantage Reimbursement Uncertainty Reshape The Bull Case For CVS Health’s Platform Strategy (CVS)?

Simply Wall St.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/stock/CVS.AU/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"CVS.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"CVS.AU\",,,,,undefined,":{"symbol":"CVS.AU","market":"AU","secType":"STK","nameCN":"Cervantes Corp Ltd","latestPrice":0.009,"timestamp":1787292000000,"preClose":0.009,"halted":0,"volume":0,"delay":0,"changeRate":0,"nameEN":"Cervantes Corp Ltd","floatShares":835997011,"shares":1910000000,"eps":-0.000482,"marketStatus":"Not Yet Opened","change":0,"latestTime":"08-21 16:00:00 AEST","open":0.009,"high":0.009,"low":0.009,"amount":53978.878479383005,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.000482,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1787529600000},"marketStatusCode":0,"adr":0,"exchange":"ASX","adjPreClose":0.009,"openAndCloseTimeList":[[1787270400000,1787292000000]],"volumeRatio":0.4288793926956469,"lotSize":1,"tradeCurrency":"AUD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"CVS.AU\",,,,,undefined,":{"symbol":"CVS.AU","floatShares":835997011,"roa":"-7.57%","roe":"-16.17%","lyrEps":-0.000482,"volumeRatio":0.4288793926956469,"shares":1910000000,"dividePrice":0,"high":0.009,"amplitude":0,"preClose":0.009,"low":0.009,"week52Low":0.009,"pbRate":"4.97","week52High":0.009,"institutionHeld":0,"latestPrice":0.009,"eps":-0.000482,"divideRate":0,"volume":0,"delay":0,"ttmEps":-0.000482,"open":0.009,"prevYearClose":0.009,"prevWeekClose":0.009,"prevMonthClose":0.009,"prevQuarterClose":0.009,"fiveDayClose":0.009,"twentyDayClose":0.009,"sixtyDayClose":0.009},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CVS.AU\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CVS.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CVS.AU\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2633124246","title":"CVS Health Increasingly Likely to Reach 3% Medicare Advantage Target Margin in 2028, RBC Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2633124246","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633124246?lang=en_us&edition=fundamental","pubTime":"2026-05-08 00:15","pubTimestamp":1778170527,"startTime":"0","endTime":"0","summary":"CVS Health  is increasingly more likely to reach its 3% Medicare Advantage target margin in 2028, RBC Capital Markets analyst said in a note Wednesday.Analysts said the company's Q1 adjusted earnings \"comfortably\" beat expectations, driven by \"strong\" topline growth and a notable improvement in profitability in the Health Care Benefits segment.Medical costs came in below expectations and, while the company maintained its medical benefit ratio guidance for the year, it is increasingly likely to outperform, according to the note.The brokerage raised its 2026 adjusted earnings estimate for the company to $7.41 from $7.10. Analysts surveyed by FactSet expect $7.29.RBC reiterated its outperform rating on the stock and increased its price target to $107 from $93.Price: 87.01, Change: +0.14, Percent Change: +0.17","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IE00B19Z3B42.SGD","IE00B7SZLL34.SGD","LU0162691827.USD","BK4585","LU1571399168.USD","LU0432979614.USD","LU0070302665.USD","BK4581","LU0211331839.USD","BK4504","BK4588","CVS.AU","IE0002270589.USD","LU1699723380.USD","CVS","LU0061475181.USD","LU0320765489.SGD","LU1059921491.USD","IE00BKVL7J92.USD","LU1983299246.USD","IE00B19Z3581.USD","BK4550","LU0072461881.USD","LU0006061336.USD","BK4196","IE00BZ1G4Q59.USD","LU0208291251.USD","IE00BSNM7G36.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633158665","title":"Sector Update: Health Care","url":"https://stock-news.laohu8.com/highlight/detail?id=2633158665","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633158665?lang=en_us&edition=fundamental","pubTime":"2026-05-07 01:08","pubTimestamp":1778087291,"startTime":"0","endTime":"0","summary":"Health care stocks were mixed Wednesday afternoon, with the NYSE Health Care Index increasing 0.1% and the State Street Health Care Select Sector SPDR ETF  shedding 0.2%.The iShares Biotechnology ETF  climbed 1.7%.In corporate news, CVS Health  raised its full-year earnings outlook after reporting better-than-expected Q1 results driven by improvement in its health-care benefits segment. Its shares gained 6.7%.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4504","IE00B7SZLL34.SGD","LU1983299246.USD","XBI","LU0432979614.USD","LU1059921491.USD","IBB","LU0006061336.USD","LU0162691827.USD","XLV","IE00BSNM7G36.USD","IE00B19Z3581.USD","LU0072461881.USD","LU0061475181.USD","BK4550","LABU","LU1571399168.USD","IE00B19Z3B42.SGD","BK4196","IE00BKVL7J92.USD","CVS","IE00BZ1G4Q59.USD","LU0211331839.USD","LU1699723380.USD","CVS.AU","BK4585","BK4588","LU0208291251.USD","LU0320765489.SGD","IE0002270589.USD","BK4581","LU0070302665.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633818961","title":"GUIDANCE: (CVS) CVS Health Expects 2026 Adjusted EPS Range $7.30 - $7.50, vs. FactSet Est of $7.16","url":"https://stock-news.laohu8.com/highlight/detail?id=2633818961","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633818961?lang=en_us&edition=fundamental","pubTime":"2026-05-06 18:34","pubTimestamp":1778063678,"startTime":"0","endTime":"0","summary":"GUIDANCE: (CVS) CVS Health Expects 2026 Adjusted EPS Range $7.30 - $7.50, vs. FactSet Est of $7.16","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["CVS.AU","CVS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632609144","title":"A Look At CVS Health (CVS) Valuation After Guidance Reaffirmation And Medicare Advantage Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2632609144","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632609144?lang=en_us&edition=fundamental","pubTime":"2026-05-03 13:32","pubTimestamp":1777786343,"startTime":"0","endTime":"0","summary":"CVS Health (CVS) is back in focus after reaffirming its earnings guidance and outlining plans to improve Aetna margins, as investors digest a higher than expected 2027 Medicare Advantage payment update and easing regulatory questions around insulin pricing.\nSee our latest analysis for CVS Health.\nThe reaffirmed earnings outlook and support for Aetna margins have arrived alongside a 30 day share price return of 11.7% and a 1 year total shareholder return of 26.1%. This suggests recent momentum...","market":"nz","thumbnail":"https://images.simplywall.st/asset/company-cover/93625-main-header/1756253484610","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/93625-main-header/1756253484610"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nyse-cvs/cvs-health/news/a-look-at-cvs-health-cvs-valuation-after-guidance-reaffirmat","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nyse-cvs/cvs-health/news/a-look-at-cvs-health-cvs-valuation-after-guidance-reaffirmat","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU1571399168.USD","LU0006061336.USD","LU0208291251.USD","LU1699723380.USD","LU1059921491.USD","LU0070302665.USD","IE00BSNM7G36.USD","LU0432979614.USD","IE00B19Z3B42.SGD","LU0211331839.USD","BK4581","LU1983299246.USD","CVS","CVS.AU","BK4585","LU0061475181.USD","LU0162691827.USD","LU0072461881.USD","IE0002270589.USD","IE00BKVL7J92.USD","IE00B7SZLL34.SGD","BK4588","BK4550","LU0320765489.SGD","BK4196","IE00BZ1G4Q59.USD","BK4504","IE00B19Z3581.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629842902","title":"CVS Health's Aetna Says 88% of Prior Authorization Volume Standardized","url":"https://stock-news.laohu8.com/highlight/detail?id=2629842902","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629842902?lang=en_us&edition=fundamental","pubTime":"2026-04-24 21:31","pubTimestamp":1777037498,"startTime":"0","endTime":"0","summary":"CVS Health's  Aetna said Friday it has standardized 88% of its prior authorization volume, exceeding industry commitments.The company said it has approved more than 95% of eligible prior authorizations within 24 hours, with 83% processed in real time, exceeding America's Health Insurance Plans' goal of 80% by 2027.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0006061336.USD","LU0211331839.USD","IE00B19Z3B42.SGD","LU0432979614.USD","BK4581","IE00BKVL7J92.USD","LU0070302665.USD","CVS.AU","CVS","LU1571399168.USD","BK4588","LU0061475181.USD","LU0162691827.USD","BK4550","AET","IE00B7SZLL34.SGD","LU1983299246.USD","IE00BSNM7G36.USD","LU1699723380.USD","LU1059921491.USD","LU0320765489.SGD","IE00B19Z3581.USD","IE0002270589.USD","BK4585","BK4504","LU0072461881.USD","IE00BZ1G4Q59.USD","BK4196","LU0208291251.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629774290","title":"Did Insulin-Settlement Tailwinds and Medicare Advantage Boosts Just Shift CVS Health's (CVS) Investment Narrative?","url":"https://stock-news.laohu8.com/highlight/detail?id=2629774290","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629774290?lang=en_us&edition=fundamental","pubTime":"2026-04-21 06:06","pubTimestamp":1776722772,"startTime":"0","endTime":"0","summary":"In mid-April 2026, analysts at UBS, Baird, and others reiterated positive views on CVS Health following its FTC insulin-pricing settlement and discussion of benefits from higher Medicare Advantage payments, even as more than 500 unionized workers at a Fredericksburg, Virginia distribution center authorized a strike that could disrupt Mid-Atlantic operations.\nAetna’s more than US$2.60 billion year-over-year adjusted operating income improvement and expectations for pharmacy benefit management...","market":"us","thumbnail":"https://images.simplywall.st/asset/company-cover/93625-main-header/1756253484610","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/93625-main-header/1756253484610"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nyse-cvs/cvs-health/news/did-insulin-settlement-tailwinds-and-medicare-advantage-boos","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nyse-cvs/cvs-health/news/did-insulin-settlement-tailwinds-and-medicare-advantage-boos","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["IE00BZ1G4Q59.USD","LU0006061336.USD","LU0211331839.USD","IE00B7SZLL34.SGD","BK4588","BK4550","IE00B19Z3581.USD","BK4196","CVS.AU","IE00BSNM7G36.USD","BK4504","CVS","LU1571399168.USD","LU0320765489.SGD","LU1699723380.USD","BK4581","BK4585","LU1059921491.USD","IE00BKVL7J92.USD","LU1983299246.USD","LU0070302665.USD","LU0072461881.USD","IE0002270589.USD","LU0208291251.USD","IE00B19Z3B42.SGD","LU0061475181.USD","LU0162691827.USD","LU0432979614.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626131661","title":"A Look At CVS Health’s Valuation As Medicare Advantage Rates Rise And FTC Insulin Concerns Ease","url":"https://stock-news.laohu8.com/highlight/detail?id=2626131661","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626131661?lang=en_us&edition=fundamental","pubTime":"2026-04-09 23:25","pubTimestamp":1775748321,"startTime":"0","endTime":"0","summary":"CVS Health (CVS) is back in focus after regulators approved higher than expected 2027 Medicare Advantage payment rates, and an anticipated FTC settlement eased concern around Caremark’s insulin pricing practices.\nSee our latest analysis for CVS Health.\nThe recent Medicare Advantage decision and easing regulatory concerns have triggered a sharp swing in sentiment, with a 7 day share price return of 8.69% at a US$78.79 share price. The 1 year total shareholder return of 16.55% points to...","market":"us","thumbnail":"https://images.simplywall.st/asset/company-cover/93625-main-header/1756253484610","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/93625-main-header/1756253484610"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nyse-cvs/cvs-health/news/a-look-at-cvs-healths-valuation-as-medicare-advantage-rates","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nyse-cvs/cvs-health/news/a-look-at-cvs-healths-valuation-as-medicare-advantage-rates","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["IE00BKVL7J92.USD","LU0061475181.USD","LU0072461881.USD","LU0162691827.USD","LU0070302665.USD","LU0432979614.USD","LU1699723380.USD","IE00B19Z3581.USD","BK4504","BK4581","CVS.AU","IE00BZ1G4Q59.USD","IE00B19Z3B42.SGD","BK4550","LU1983299246.USD","LU0211331839.USD","CVS","LU1571399168.USD","LU0320765489.SGD","IE0002270589.USD","BK4196","LU0006061336.USD","LU0208291251.USD","LU1059921491.USD","FTC","BK4588","IE00B7SZLL34.SGD","BK4585","IE00BSNM7G36.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625937810","title":"Top Premarket Gainers","url":"https://stock-news.laohu8.com/highlight/detail?id=2625937810","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625937810?lang=en_us&edition=fundamental","pubTime":"2026-04-07 19:26","pubTimestamp":1775561197,"startTime":"0","endTime":"0","summary":"Advanced Biomed  shares were 87% higher pre-bell Tuesday following a 2.9% loss in the previous session.Mawson Infrastructure Group  stock was up 20% after the company said late Monday it signed a cooperation agreement with The Endeavor Investor Group to reconstitute its board.Humana  shares were 9% higher after the Centers for Medicare & Medicaid Services announced a larger-than-expected increase to Medicare Advantage payments for 2027.CVS Health  stock was up 7% following a muted session.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7093","LU1093756168.USD","IE00B19Z3B42.SGD","LU0072461881.USD","ADVB","BK4585","IE00BSNM7G36.USD","LU0320765489.SGD","LU0266013472.USD","LU0238689110.USD","BK4198","HUM.AU","BK4550","HUM","IE00BKVL7J92.USD","BK4023","LU0070302665.USD","LU0348723411.USD","LU1571399168.USD","IE00B19Z3581.USD","LU1983299246.USD","LU0061475181.USD","BK4504","CVS.AU","BK4600","LU0006061336.USD","BK4581","LU0432979614.USD","SG9999014021.USD","BK4588","SG9999014013.SGD","LU0211331839.USD","SG9999014005.SGD","BK7500","BK4154","LU1983260115.SGD","IE00BZ1G4Q59.USD","CVS","LU1093756325.SGD","MIGI","BK4595","IE00B7SZLL34.SGD","BK4533","LU0162691827.USD","LU1699723380.USD","LU0170899867.USD","LU1059921491.USD","BK4196","LU0390134368.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622717862","title":"Antitrust Lawsuit Targeting CVS, Colgate-Palmolive, Other Firms Dismissed by Federal Judge","url":"https://stock-news.laohu8.com/highlight/detail?id=2622717862","media":"MT Newswires Live","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622717862?lang=en_us&edition=fundamental","pubTime":"2026-03-27 00:25","pubTimestamp":1774542339,"startTime":"0","endTime":"0","summary":"An antitrust lawsuit targeting CVS Health , Colgate-Palmolive  and other companies by the social media platform X has been dismissed, according to a court filing on Thursday.The lawsuit, which alleged that the companies and the World Federation of Advertisers illegally boycotted the platform, was dismissed by US District Judge Jane Boyle because X had failed to show it had suffered harm under antitrust laws, according to the filing.The lawsuit was filed in the US District Court for the Northern District of Texas.Price: 71.92, Change: -0.26, Percent Change: -0.36","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["US12M.BOND","IE00BSNM7G36.USD","US2Y.BOND","LU1059921491.USD","TLTW","US3Y.BOND","CVS.AU","US5Y.BOND","US6M.BOND","BK4532","BK4550","LU1150488135.SGD","US7Y.BOND","BK4018","LU0061475181.USD","LU0731783394.SGD","US30Y.BOND","CL","IE00BZ1G4Q59.USD","LU0006061336.USD","LU0323591593.USD","LU0345770993.USD","LU0266013472.USD","LU0320765489.SGD","LU1941712348.USD","LU2463526074.USD","SG9999001440.SGD","LU0070302665.USD","CVS","IE0002270589.USD","TMF","IE00B7SZLL34.SGD","LU0345770308.USD","BK4196","LU0162691827.USD","LU1941712264.USD","BK4581","IE00B19Z3B42.SGD","LU1585245621.USD","BK4585","LU2360032135.SGD","LU1236620834.HKD","LU0211331839.USD","BK4504","LU2108987350.USD","US10Y.BOND","LU1599440770.SGD","LU1150488218.USD","LU1571399168.USD"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2622001336","title":"Should FTC Insulin Settlement And PBM Lawsuit Shift How Investors View CVS Health’s (CVS) Risk-Reward Profile?","url":"https://stock-news.laohu8.com/highlight/detail?id=2622001336","media":"Simply Wall St.","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622001336?lang=en_us&edition=fundamental","pubTime":"2026-03-26 02:14","pubTimestamp":1774462482,"startTime":"0","endTime":"0","summary":"CVS Health recently reached a proposed settlement with the Federal Trade Commission over insulin pricing practices in its Caremark pharmacy benefit manager unit, while also facing a new class action lawsuit alleging improper formulary-related fees. \nAt the same time, CVS Health’s board affirmed its quarterly US$0.665 dividend and added former Elevance Health CFO John E. Gallina as an audit committee financial expert, underscoring governance and capital-return priorities amid regulatory...","market":"sg","thumbnail":"https://images.simplywall.st/asset/company-cover/93625-main-header/1756253484610","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/93625-main-header/1756253484610"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nyse-cvs/cvs-health/news/should-ftc-insulin-settlement-and-pbm-lawsuit-shift-how-inve","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nyse-cvs/cvs-health/news/should-ftc-insulin-settlement-and-pbm-lawsuit-shift-how-inve","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4211","LU0006061336.USD","AI","CVS.AU","BK4587","LU1571399168.USD","LU0070302665.USD","BK4585","BK4139","FTC","PBM","BK4504","BK4550","IE00B19Z3581.USD","LU0432979614.USD","LU0211331839.USD","BK4588","IE00BSNM7G36.USD","LU0061475181.USD","BK4543","LU0162691827.USD","IE00B19Z3B42.SGD","LU0320765489.SGD","CVS","BK4528","BK4551","IE0002270589.USD","LU1983299246.USD","LU1699723380.USD","CHAT","ISBC","AGIX","IE00B7SZLL34.SGD","AIPO","AIYY","BK4023","LU0072461881.USD","BK4581","IE00BKVL7J92.USD","IE00BZ1G4Q59.USD","BK4196","LU0208291251.USD","LU1059921491.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622018994","title":"Sector Update: Health Care Stocks Advance Late Afternoon","url":"https://stock-news.laohu8.com/highlight/detail?id=2622018994","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622018994?lang=en_us&edition=fundamental","pubTime":"2026-03-25 03:50","pubTimestamp":1774381826,"startTime":"0","endTime":"0","summary":"Health care stocks rose late Tuesday afternoon, with the NYSE Health Care Index adding 0.4% and the State Street Health Care Select Sector SPDR ETF  up 0.2%.The iShares Biotechnology ETF  shed 0.4%.In corporate news, CVS Health  has reached a proposed settlement with the Federal Trade Commission over insulin pricing, Reuters reported, citing the company. The company's pharmacy benefit management unit, Caremark, has focused on lowering prescription drug costs, CVS said, adding that the settlement is expected to be finalized in the coming weeks, with final terms still pending, the report said. CVS shares rose 2.5%.ImmunityBio  shares dropped 21% after the US Food and Drug Administration issued a warning letter citing \"misleading\" promotional materials for its bladder cancer drug Anktiva.Gilead Sciences  has agreed to acquire autoimmune disease therapy developer Ouro Medicines for up to $2.18 billion, while the biopharmaceutical firm is in collaboration talks with Galapagos  on the assets","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0070302665.USD","LU0289739699.SGD","LU0211331839.USD","BK4196","CVS","LU1934455277.USD","LU0114720955.EUR","LU2087621335.USD","LU0109394709.USD","IE00BSNM7G36.USD","LU1934455194.USD","IBB","LU0234570918.USD","LU0965509283.SGD","CVS.AU","LU1059921491.USD","LU0823416689.USD","BK4139","BK4504","LU1061106388.HKD","LU1674673691.USD","GILD","BK4588","LU0058720904.USD","LU2112291526.USD","XLV","LU1066051498.USD","SG9999015986.USD","LU0208291251.USD","BK4550","IE00B7SZLL34.SGD","LU0061475181.USD","IBRX","XBI","LU0965509010.AUD","KPTI","LU0861579265.USD","LU1699723380.USD","LU0072461881.USD","LU2089984988.USD","LU0889565916.HKD","GLPG","IE00BZ1G4Q59.USD","IE00B19Z3B42.SGD","LU1778281490.HKD","LABU","LU1066053197.SGD","LU0965508806.USD","IE0002270589.USD","LU0006061336.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621950650","title":"A Look At CVS Health (CVS) Valuation After Google Cloud Deal Board Change Lawsuit And Dividend News","url":"https://stock-news.laohu8.com/highlight/detail?id=2621950650","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621950650?lang=en_us&edition=fundamental","pubTime":"2026-03-24 22:08","pubTimestamp":1774361313,"startTime":"0","endTime":"0","summary":"CVS Health (CVS) is back in focus after a packed March, with a new Google Cloud partnership on healthcare technology, a fresh board appointment, an affirmed dividend, and a high profile class action targeting its PBM unit.\nSee our latest analysis for CVS Health.\nDespite the headlines around the Google Cloud partnership, dividend affirmation, leadership change and PBM lawsuit, the share price has seen a 6% decline over the last 7 days and an 11% year to date share price decline, while the 1...","market":"nz","thumbnail":"https://images.simplywall.st/asset/company-cover/93625-main-header/1756253484610","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/93625-main-header/1756253484610"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nyse-cvs/cvs-health/news/a-look-at-cvs-health-cvs-valuation-after-google-cloud-deal-b","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nyse-cvs/cvs-health/news/a-look-at-cvs-health-cvs-valuation-after-google-cloud-deal-b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU1571399168.USD","LU0162691827.USD","BK4585","LU0432979614.USD","LU0070302665.USD","IE00BKVL7J92.USD","BK4581","BK4504","IE00B19Z3B42.SGD","IE0002270589.USD","CVS.AU","CVS","LU1983299246.USD","LU1699723380.USD","BK4550","LU0006061336.USD","LU0072461881.USD","LU0208291251.USD","LU0320765489.SGD","BK4196","LU0211331839.USD","IE00B7SZLL34.SGD","LU0061475181.USD","BK4588","IE00BZ1G4Q59.USD","IE00B19Z3581.USD","IE00BSNM7G36.USD","LU1059921491.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614986062","title":"Is CVS Health (CVS) Pricing Look Interesting After Recent 1 Year Share Price Recovery","url":"https://stock-news.laohu8.com/highlight/detail?id=2614986062","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614986062?lang=en_us&edition=fundamental","pubTime":"2026-02-28 04:38","pubTimestamp":1772224699,"startTime":"0","endTime":"0","summary":"If you are wondering whether CVS Health is fairly priced or offering value at its recent levels, you are not alone. This article will walk through what the numbers suggest.\nThe stock last closed at US$78.01, with returns of 0.9% over the past 7 days, 8.3% over 30 days, a 2.6% decline year to date, and 25.6% over 1 year. This gives investors a mix of recent momentum and earlier pullbacks to think about.\nRecent news coverage has focused on CVS Health's position as a large integrated healthcare...","market":"us","thumbnail":"https://images.simplywall.st/asset/company-cover/93625-main-header/1756253484610","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/93625-main-header/1756253484610"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nyse-cvs/cvs-health/news/is-cvs-health-cvs-pricing-look-interesting-after-recent-1-ye","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nyse-cvs/cvs-health/news/is-cvs-health-cvs-pricing-look-interesting-after-recent-1-ye","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["IE00BSNM7G36.USD","LU1059921491.USD","CVS.AU","BK4550","LU0061475181.USD","LU0208291251.USD","BK4588","IE00BKVL7J92.USD","IE00BZ1G4Q59.USD","LU0006061336.USD","LU0432979614.USD","LU1699723380.USD","IE00B19Z3581.USD","LU0320765489.SGD","LU0070302665.USD","CVS","IE0002270589.USD","IE00B7SZLL34.SGD","BK4196","LU0162691827.USD","BK4581","IE00B19Z3B42.SGD","BK4585","LU0072461881.USD","DCF","LU0211331839.USD","BK4504","LU1983299246.USD","LU1571399168.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614706183","title":"Does Medicare Advantage Reimbursement Uncertainty Reshape The Bull Case For CVS Health’s Platform Strategy (CVS)?","url":"https://stock-news.laohu8.com/highlight/detail?id=2614706183","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614706183?lang=en_us&edition=fundamental","pubTime":"2026-02-26 09:38","pubTimestamp":1772069883,"startTime":"0","endTime":"0","summary":"Earlier in February, CVS Health faced investor concerns after federal Medicare officials proposed minimal payment updates and risk‑adjustment changes for 2027 Medicare Advantage plans, raising questions about reimbursement levels for its Aetna insurance unit.\nAt the same time, heightened put option activity and ongoing integration of Oak Street Health, alongside legal settlements and new sports health partnerships, underscored how policy risk, primary care expansion, and brand-building...","market":"nz","thumbnail":"https://images.simplywall.st/asset/company-cover/93625-main-header/1756253484610","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/93625-main-header/1756253484610"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nyse-cvs/cvs-health/news/does-medicare-advantage-reimbursement-uncertainty-reshape-th","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nyse-cvs/cvs-health/news/does-medicare-advantage-reimbursement-uncertainty-reshape-th","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4504","IE00B7SZLL34.SGD","LU1983299246.USD","AIYY","LU0432979614.USD","BK4551","LU1059921491.USD","LU0006061336.USD","LU0162691827.USD","IE00BSNM7G36.USD","AI","IE00B19Z3581.USD","BK4528","LU0072461881.USD","LU0061475181.USD","BK4550","BK4023","LU1571399168.USD","IE00B19Z3B42.SGD","BK4196","IE00BKVL7J92.USD","CVS","IE00BZ1G4Q59.USD","LU0211331839.USD","LU1699723380.USD","CVS.AU","BK4585","BK4588","BK4587","LU0208291251.USD","LU0320765489.SGD","IE0002270589.USD","BK4543","BK4581","LU0070302665.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":2,"totalSize":34,"code":"91000000","status":"200"}]}}